As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 7/26/23  Viking Therapeutics, Inc.         10-Q        6/30/23   56:9.7M                                   Donnelley … Solutions/FA 
 7/28/21  Viking Therapeutics, Inc.         S-3                    5:1.6M                                   ActiveDisclosure/FA      

____________
¹	Filing/Form Types:  -K
	10-Q	Quarterly Report — Form 10-Q.
	S-3	Registration Statement – Securities for a Transaction — Form S-3.